SARS-Cov-2
COVID-19 pandemic exacerbated weaknesses in patient safety, APIC says
The leading U.S. professional association for infection preventionists published recommendations on Tuesday that it said will ensure the country is better prepared to protect patients during a health emergency like COVID-19.
Boston sites will recruit more than 900 people for long COVID study
Six Boston area hospitals will recruit more than 900 participants for a multiyear study of the effects of long COVID.
‘We have the tools to protect each other’: White House unveils new COVID-19 plan
On the heels of President Joe Biden’s State of the Union address, his administration announced a new National COVID-19 Preparedness Plan, which includes a test-to-treat initiative.
Real-world evidence shows Pfizer-BioNTech vaccine effective in kids, adolescents
Real-world evidence published Tuesday in MMWR demonstrated that the Pfizer-BioNTech vaccine has protected children and adolescents against COVID-19, including kids aged 5 to 11 years.
NFL’s test-to-release strategy helped vaccinated players shorten isolation time
The NFL’s COVID-19 test-to-release protocol, implemented in December during the omicron surge, helped NFL players and staff members shorten their isolation time, according to a study published in MMWR.
Third of adults aged 65 years or older at risk for one or more long COVID symptoms
One in three older adults reported one or more new or persistent COVID-19 symptoms following acute SARS-CoV-2 infection, researchers reported in BMJ.
CDC’s new COVID-19 metrics indicate most Americans can go maskless
New COVID-19 guidance released by the CDC on Friday indicates that most Americans now live in areas where they can go maskless.
Sanofi, GSK will seek authorization for COVID-19 vaccine
Sanofi and GSK announced Wednesday that they will submit data from booster and phase 3 efficacy trials to support authorization of their two-dose protein-based COVID-19 vaccine.
Interval between COVID-19 vaccine doses can be 8 weeks for some people, CDC says
The interval between the first and second doses of the Pfizer-BioNTech and Moderna COVID-19 vaccines can be up to 8 weeks for certain people, the CDC said in updated interim guidance.
Q&A: Negative PCR tests 'should not preclude evidence-based COVID-19 treatment'
Physicians should practice clinical judgment when treating patients who have a negative PCR test despite clear COVID-19 signs or symptoms and no alternative diagnosis, according to researchers.